“Ongoing pandemic (tuberculosis) response and future pandemic preparedness – How to make synergy.”
The 2023 UN High-Level Meeting will take place on September 20 agenda as they recommit to ending tuberculosis (TB), delivering universal health coverage (UHC) and strengthening pandemic prevention, preparedness, and response.
Aligned with this UN General Assembly, the Global Health Innovative Technology Fund (GHIT Fund), in collaboration with Nikkei Inc., Government of Japan and Stop TB Partnership will hold a side event titled “Ongoing Pandemic (tuberculosis) response and future pandemic preparedness - How to make synergy” in New York, USA, on September 22.
Join us for a lively discussion on how Japan can contribute to the fight against communicable diseases in the post-COVID world.
Bringing together representatives from international organizations, government officials, the private sector and civil society, this event will highlight how we can tackle future pandemic by looking into the synergies we can expect from the current pandemic (tuberculosis) response.
The discussion here will be taken back to the 10th Nikkei FT Communicable Diseases Conference, to be held in Tokyo on 16-18 October 2023, to develop and translate into concrete action plans.
Participation will be onsite in New York only. (No online sessions will be held.)
We look forward to your participation.
Please note that a lottery may be held if the total number of enrolled applicants exceeds the number of seats available.
Event Topic “Ongoing pandemic (tuberculosis) response and future pandemic preparedness – How to make synergy.”
Date and Time:September 22, 2023
17:00-18:00 Networking Reception
(Please enjoy Sushi and Sake while networking)
18:00-18:15 Opening Remarks
SHINO Mitsuko, H.E. Ambassador, Deputy Permanent Representative of Japan to the United Nations
Shigeru OMI, Chairman, Japan Anti-Tuberculosis Association (JATA)
18:15-20:15 Panel Discussion (18:15-20:15)
Moderator: Osamu KUNII, CEO, Global Health Innovative Technology Fund(GHIT Fund)
Lucica DITIU, Executie Director, Stop TB Partnership
Richard HATCHETT, CEO, CEPI
Claire WINGFIELD, Director, Partnerships & Advocacy, FIND
/Willo BROCK, Executive Vice President, External Affairs, FIND
Rachel M. COHEN, Senior Advisor, Global Policy Advocacy & Access, Drugs for Neglected Diseases initiative (DNDi)
Olya KLYMENKO, Chairperson of the Board, TB Survivor in Ukraine,
Eliud WANDWALO, Head of Tuberculosis, Technical Advice and Partnerships Department, Global Fund
Masataka AKIYAMA, Director, Corporate Vice President, General Manager, Medical Systems Business Div., Fujifilm Corporation
Teik Jun BEH, Clinical Strategy Director, Remedy & Company Corporation
Eiji HINOSHITA, Assistant Minister for Global Health and Welfare, Japanese Ministry of Health, Labour and Welfare
Seiya KATO, Director, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association (RIT/JATA)
Akira SHIMOUCHI, Project Director “Strengthening Urban TB Control Program in Kathmandu”, JATA Nepal Office [video message]
Mathume Joseph PHAAHLA, Minister of Health, Govt. of South Africa (tbc)
Ibrahim ABUBAKAR, Dean, Faculty of Population Health Sciences, University College London
20:15-20:30 Closing Remarks
Co-Organizer: Global Health Innovative Technology Fund (GHIT Fund), Government of Japan and Stop TB Partnership
Sponsor: Japan Airlines
NIKKEI FT Communicable Diseases Conference